Abstract. Cerebrospinal fluid (CSF) biomarkers for Alzheimer's disease (AD) are increasingly used in research centers, clinical trials, and clinical settings. However, their broad-scale use is hampered by lack of standardization across analytical platforms and by interference from binding of amyloid-␤ (A␤) to matrix proteins as well as self-aggregation. Here, we report on a matrix effectresistant method for the measurement of the AD-associated 42 amino acid species of A␤ (A␤ 42 ), together with A␤ 40 and A␤ 38 in human CSF based on mass spectrometric quantification using selected reaction monitoring (SRM). Samples were prepared by solid-phase extraction and quantification was performed using stable-isotope labeled A␤ peptides as internal standards. The diagnostic performance of the method was evaluated on two independent clinical materials with research volunteers who were cognitively normal and AD patients with mild to moderate dementia. Analytical characteristics of the method include a lower limit of quantification of 62.5 pg/mL for A␤ 42 and coefficients of variations below 10%. In a pilot study on AD patients and controls, we verified disease-association with decreased levels of A␤ 42 similar to that obtained by ELISA and even better separation was 
INTRODUCTION

29
Alzheimer's disease (AD), the main cause of 
120
MATERIAL AND METHODS
121
Participants and CSF collection 122
In the present study we analyzed CSF samples from 123 15 AD patients, mean age ± SD: 75.6 ± 6.6 years, and 124 15 healthy controls, mean age ± SD: 66.3 ± 9.8 years.
125
A second set of CSF samples from 15 AD patients
126
(mean age ± SD: 81 ± 5.0 years) and 15 healthy 127 controls (mean age ± SD: 63.9 ± 9.4 years) were ana- (1 : 2) five times with CSF from the same pool (Fig. 1a) .
176
Three replicates of each dilution were analyzed.
177
The performance of the method including sensitiv- at room temperature, and centrifuged briefly (Fig. 1b) .
201
SRM analysis
202
Samples (20 L) were injected on a reversed- Prior to analysis the dried samples are redissolved with 25 L 1% NH 4 OH in 20% ACN. The samples are then injected serially on a reversed phase column which separates the peptides according to their hydrophobicity. Since the shorter A␤ peptides are less hydrophobic than the longer species, they elute earlier while co-eluting with their corresponding internal standard. The time from injection to injection is 20 minutes. The A␤ peptides are ionized using electrospray and transmitted through the first quadrupole according to their m/z values to the second quadrupole which is filled with argon. Here the peptides are fragmented as they collide with the gas atoms and only specific fragments of the A␤ peptides with predefined m/z values are transmitted through the third quadrupole and further to the detector. for each peptide and used for quantification (Table 1) .
274
The LC gradient was optimized for a short analysis and 5% (Fig. 4) . For A␤ 42 , intra-assay CVs were 12% 286 at 350 pg/mL and 6% at 1214 pg/mL, respectively.
287
The influence of GdnHCl on the levels of A␤ 42 mea- 
290
No significant difference was observed (<5%).
291
To test the ability of the SRM assay to separate 292 AD patients from controls, we determined the con- (d) . Absolute concentration of endogenous A␤ peptide is calculated using the area ratio for the co-eluting internal standard of known concentration.
sensitivity of 93% and specificity of 80% compared to 307 ELISA (Fig. 5b, c) and a sensitivity and specificity of (Fig. 5d, e and 6d, e) .
311
DISCUSSION
312
We here report on the development of an antibody-313 independent, matrix effect resistant assay for quantifi-314 cation of A␤ 42 , A␤ 40 , and A␤ 38 using SRM-based To achieve high specificity and stability over time, 
